All sponsors

Yuhan Corporation $000100.KS

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS5
PHASE 3 / 2-31
RECRUITING5
READOUTS ≤12 MONTHS2
Open Yuhan Corporation on the live radar map → 📅 $000100.KS readout calendar (.ics)
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
NTCB02-1
NCT06625957
P3RecruitingParenteral Nutrition602025-07-18
YH32364
NCT06975410
P1/2RecruitingEGFR Overexpression; Locally Advanced Solid Tumor802027-06
CLEAR
NCT07415551
P2RecruitingAllergic Diseases; Chronic Spontaneous Urticaria (CSU)1502027-06-19
YH42946
NCT06616766
P1/2RecruitingNSCLC (Non-small Cell Lung Cancer); Solid Tumor2012028-03-15
YH32367
NCT05523947
P1/2RecruitingHER2-Positive Solid Tumor1472028-03-31 (+50 mo)